Stephen Steinour Purchases 6,700 Shares of Bath & Body Works (NYSE:BBWI) Stock

Bath & Body Works, Inc. (NYSE:BBWI) Director Stephen Steinour bought 6,700 shares of Bath & Body Works stock in a transaction dated Friday, November 21st. The shares were bought at an average price of $14.86 per share, for a total transaction of $99,562.00. Following the completion of the transaction, the director directly owned 48,175 shares of the company’s stock, valued at $715,880.50. This represents a 16.15% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link.

Bath & Body Works Price Performance

Shares of NYSE BBWI traded up $0.73 during midday trading on Monday, hitting $15.58. The stock had a trading volume of 18,349,612 shares, compared to its average volume of 5,908,003. The company’s 50-day simple moving average is $24.58 and its 200 day simple moving average is $28.11. The firm has a market cap of $3.21 billion, a P/E ratio of 4.62, a price-to-earnings-growth ratio of 0.86 and a beta of 1.53. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $41.87.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, November 20th. The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period last year, the business posted $0.49 EPS. The firm’s revenue for the quarter was down 1.0% compared to the same quarter last year. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. Equities analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 5th. Stockholders of record on Friday, November 21st will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, November 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 5.1%. Bath & Body Works’s dividend payout ratio is 24.62%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. UBS Group decreased their price objective on Bath & Body Works from $32.00 to $17.00 and set a “neutral” rating for the company in a research note on Friday. Citigroup reduced their target price on Bath & Body Works from $35.00 to $21.00 and set a “buy” rating on the stock in a report on Friday. The Goldman Sachs Group cut Bath & Body Works from a “buy” rating to a “neutral” rating and lowered their price target for the company from $39.00 to $17.00 in a research note on Thursday. Baird R W downgraded shares of Bath & Body Works from a “strong-buy” rating to a “hold” rating in a research report on Friday. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Bath & Body Works in a report on Wednesday, October 8th. Seven analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $26.84.

Institutional Trading of Bath & Body Works

Hedge funds have recently bought and sold shares of the stock. T. Rowe Price Investment Management Inc. boosted its holdings in shares of Bath & Body Works by 7.6% in the first quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock valued at $334,029,000 after buying an additional 781,681 shares during the period. JPMorgan Chase & Co. lifted its position in Bath & Body Works by 11.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock valued at $212,120,000 after acquiring an additional 733,000 shares in the last quarter. Alliancebernstein L.P. lifted its position in Bath & Body Works by 2.2% in the 3rd quarter. Alliancebernstein L.P. now owns 5,861,444 shares of the company’s stock valued at $150,991,000 after acquiring an additional 123,648 shares in the last quarter. Cooper Creek Partners Management LLC boosted its stake in Bath & Body Works by 42.7% in the 2nd quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company’s stock worth $162,081,000 after purchasing an additional 1,619,276 shares during the period. Finally, American Century Companies Inc. increased its holdings in Bath & Body Works by 2,204.1% during the 3rd quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock worth $133,292,000 after purchasing an additional 4,949,796 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.